Do we need a new breast augmentation option? According to The Aesthetic Society’s recent report, breast augmentations are down 2.2% from last year. Although this is a small dip, it reflects a decrease in the desire for breast augmentation using traditional implants. Today’s alternatives include fat transfer, breast lift, reduction, and a new contender: the Mia Femtech procedure. Unlike traditional breast implants, this procedure aims to “harmonize” the breasts and offers a modest volume boost without leaving a scar.
Featured Experts
What is an “injectable” breast implant?
The term “injectable” can be a bit misleading. Mia Femtech implants are not liquid fillers, but are silicone implants with a flexible gel inside. Louisville, KY plastic surgeon M. Bradley Calobrace, MD explains, “Mia Femtech injectable breast implants use a new nano-surface on the shell, which allows insertion through a small incision. An insertion device is used to keep the incision small, making it easier and less invasive.” Unlike traditional implants that often require larger incisions and more extensive surgery, Mia Femtech implants are designed to provide faster recovery with minimal scarring.
How is it different from traditional implants?
“The main benefits include smaller incisions, low complication rates, faster recovery and more natural results,” says Dr. Calobrace. “Also, the implant is diamond-shaped, so it looks the same on both sides, even if it’s flipped over.”
If you are looking for a one to two cup size enhancement without cutting breast tissue, then the Mia Femtech may be a good option. The procedure is said to yield faster recovery times, with no visible incisions. “The implants are placed over the muscle,” he says.
Clinical trials and safety
Dr. Calobrace notes, “Potential risks or side effects are similar to any breast augmentation, but rupture rates and capsular contracture rates are extremely low compared to other implants.” According to a two-year study conducted by the company with 100 people between December 2020 and April 2021, there were no reports of capsular contracture or tears. A substudy of 33 subjects who underwent MRI at 18 months also reported no lacerations, bleeding, hematoma, or serosa requiring intervention.
Not yet FDA approved
Despite its promising features, the Mia Femtech procedure has not yet been approved by the FDA. It has been approved and released in other countries, including Japan and parts of Europe. Tucson, AZ plastic surgeon Raman Mahabir, MD warns, “It’s a textured silicone gel breast implant with silicone gel filling. There are concerns about textured implants with a risk of anaplastic large cell lymphoma, similar to issues seen with the Allergan recalls. While Mia Femtech has a slightly different texture, it may still carry risks and I don’t see them being approved for some time.”
Expectations and Costs
Dr. Calobrace tells us that the US cost for this injectable breast implant has yet to be determined. While still so new, Mia Femtech offers a glimpse into the future of breast augmentation, promising less invasive procedures, faster recovery times and natural results. However, patients should be aware of the current FDA status and consult with qualified, board-certified plastic surgeons to fully understand the risks and benefits.
